An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs

Study Identifier
P19-423
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Hepatitis
  • Study Drug
    N/A
    Phase
    N/A
    Sex
    Female & Male
    Age
    12+ years

    Protocol Summary

    Post-marketing surveillance study to evaluate the real world safety and effectiveness of Maviret (Glecaprevir/Pibrentasvir) administered under a normal, routine treatment practice by Korean patients with Chronic Hepatitis C Genotypes 1 to 6

    Study Locations

    Location
    Status
    Location
    SoonChunHyang University CheonAn Hospital /ID# 209996
    Cheonan-si, Chungcheongnam-do, Republic of Korea, 31151
    Status
    Not applicable
    Location
    Hallym University Sacred Heart Hospital /ID# 210809
    Anyang, Gyeonggido, Republic of Korea, 14068
    Status
    Not applicable
    Location
    The Catholic University of Korea, Bucheon St.Mary's Hospital /ID# 216869
    Bucheon-si, Gyeonggido, Republic of Korea, 14647
    Status
    Not applicable
    Location
    Dongguk University Ilsan Hospital /ID# 210609
    Goyang, Gyeonggido, Republic of Korea, 10325
    Status
    Not applicable
    Location
    National health insurance Service ilsanhospital /ID# 209997
    Goyang, Gyeonggido, Republic of Korea, 10444
    Status
    Not applicable
    Location
    SoonChunHyang University Buchon Hospital /ID# 210618
    Habun, Gyeonggido, Republic of Korea, 14584
    Status
    Not applicable
    Showing {first} - {last} of {total} Results